Medicine in the Fourth Dimension

Cederroth, C. R.; Albrecht, U.; Bass, J.; Brown, S. A.; Dyhrfjeld-Johnsen, J.; Gachon, F.; Green, C. B.; Hastings, M. H.; Helfrich-Forster, C.; Hogenesch, J. B.; Levi, F.; Loudon, A.; Lundkvist, G.B.; Meijer, J. H.; Rosbash, M.; Takahashi, J. S.; Young, M.; Canlon, B.

doi:10.1016/j.cmet.2019.06.019

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Medicine in the Fourth Dimension

MPS-Authors

/persons/resource/persons281637

Lundkvist, G.B.
Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

https://www.ncbi.nlm.nih.gov/pubmed/31390550
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Cederroth, C. R., Albrecht, U., Bass, J., Brown, S. A., Dyhrfjeld-Johnsen, J., Gachon, F., et al. (2019). Medicine in the Fourth Dimension. Cell Metab, 30(2), 238-250. doi:10.1016/j.cmet.2019.06.019.

Cite as: https://hdl.handle.net/21.11116/0000-000B-431D-A

Abstract

The importance of circadian biology has rarely been considered in pre-clinical studies, and even more when translating to the bedside. Circadian biology is becoming a critical factor for improving drug efficacy and diminishing drug toxicity. Indeed, there is emerging evidence showing that some drugs are more effective at nighttime than daytime, whereas for others it is the opposite. This suggests that the biology of the target cell will determine how an organ will respond to a drug at a specific time of the day, thus modulating pharmacodynamics. Thus, it is now time that circadian factors become an integral part of translational research.